Sudhamsh Desai: The molecular mechanisms of resistance to widely used therapeutics in MDS and AML

Sudhamsh Desai, Resident Physician Internal Medicine at Albert Einstein College of Medicine, made the following post on Twitter:

“Excited to share our recently published review exploring the molecular mechanisms of resistance to widely used therapeutics (HMAs and BCL2 inhibitors) in MDS and AML. Always grateful to my mentor Aditi Shastri for this opportunity.”

For details click here.
Source: Sudhamsh Desai/Twitter